ting End Date
NDA NDA020329 04/26/1994
GLIPIZIDE XL
glipizide tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 59762-5032
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
glipizide(glipizide) glipizide 5mg
Inactive Ingredients
Ingredient Name Strength
polyethylene glycol
hypromellose
magnesium stearate
sodium chloride
ferric oxide red
cellulose acetate
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 8mm
Flavor Imprint Code GLIPIZIDE;XL;5
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 59762-5032-1 100TABLETIn1BOTTLE None
2 59762-5032-2 500TABLETIn1BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020329 04/26/1994
GLIPIZIDE XL
glipizide tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 59762-5033
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
glipizide(glipizide) glipizide 10mg
Inactive Ingredients
Ingredient Name Strength
polyethylene glycol
hypromellose
magnesium stearate
sodium chloride
ferric oxide red
cellulose acetate
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 10mm
Flavor Imprint Code GLIPIZIDE;XL;10
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 59762-5033-1 100TABLETIn1BOTTLE None
2 59762-5033-2 500TABLETIn1BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020329 04/26/1994
Labeler -Greenstone LLC(825560733)
Establishment
Name Address ID/FEI Operations
Pfizer Pharmaceuticals LLC 829084545 MANUFACTURE
Establishment
Name Address ID/FEI Operations
Antibiotico S.p.A 433371143 API MANUFACTURE
